Invention Grant
- Patent Title: Methods for treatment of retinal disease by photoreceptor gene expression modulation
-
Application No.: US15561805Application Date: 2016-03-28
-
Publication No.: US10363256B2Publication Date: 2019-07-30
- Inventor: Thomas A. Reh , Paul Nakamura , Sheng Ding
- Applicant: University of Washington , The J. David Gladsone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone
- Applicant Address: US WA Seattle US CA San Francisco
- Assignee: University of Washington,The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone
- Current Assignee: University of Washington,The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone
- Current Assignee Address: US WA Seattle US CA San Francisco
- Agency: Christensen O'Connor Johnson Kindness PLLC
- International Application: PCT/US2016/024549 WO 20160328
- International Announcement: WO2016/160718 WO 20161006
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61P27/02 ; A61K31/426 ; A61K31/519 ; C07D495/04
Abstract:
Methods for decreasing rod gene expression in a retina, methods for decreasing the protein products expressed by rod genes in a retina, methods for treating a disease or condition treatable by decreasing rod gene expression or their protein products in a retina, and methods for treating a retinal disease in a subject.
Public/Granted literature
- US20180125847A1 METHODS FOR TREATMENT OF RETINAL DISEASE BY PHOTORECEPTOR GENE EXPRESSION MODULATION Public/Granted day:2018-05-10
Information query
